Meiji Yasuda Life Insurance’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21M Buy
866,000
+111,000
+15% +$2.69M 0.7% 9
2026
Q1
$18.3M Buy
755,000
+187,000
+33% +$4.54M 0.63% 10
2025
Q4
$13.8M Buy
568,000
+203,000
+56% +$4.93M 0.4% 16
2025
Q3
$8.88M Buy
365,000
+192,000
+111% +$4.66M 0.26% 17
2025
Q2
$4.2M Buy
+173,000
New +$4.17M 0.12% 29

Other funds holding IBDS

Meiji Yasuda Life Insurance's IBDS Position: Q2 2026 in Review

Meiji Yasuda Life Insurance increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 15% in Q2 2026, buying an estimated $2.69M and bringing the position to 866,000 shares worth $21M. The position accounts for 0.7% of the portfolio, ranked #9.

Meiji Yasuda Life Insurance first reported a position in IBDS in Q2 2025 and has held it in 5 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Meiji Yasuda Life Insurance held 866,000 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $21M as of Q2 2026.
  • Meiji Yasuda Life Insurance bought 111,000 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $2.69M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.7% of Meiji Yasuda Life Insurance's portfolio in Q2 2026, its #9 holding.
  • Meiji Yasuda Life Insurance first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.